Atara Biotherapeutics, Inc 10-Q for FY2023 Q2
Atara Biotherapeutics, Inc. (ATRA)
10-Q
2023-08-08
For: 2023-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Atara Biotherapeutics, Inc filed this 10-Q on August 8, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $957K
- down 98.1% from $51.58M a year earlier
- Net loss
- $71.11M
- compared with net income of $18.47M a year earlier
- Diluted EPS
- -$0.68
- compared with $0.18 a year earlier